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Cardiomyopathy in alcoholics is considered to be asso-
ciated with a low incidence of hepatic cirrhosis. To eval-
uate cardiac hemodynamics in alcoholic liver disease,
left ventricular function in 37 patients with hepatic cir-
rhosis (group II) was compared with that in 13 normal
subjects (group I) matched for age, sex and cardiac size.
These groups were contrasted with group III, compris-
ing 32 alcoholics without cirrhosis who had cardiac
symptoms but no cardiomegaly or heart failure. Patients
with cirrhosis as a group did not differ from normal
subjects (group I) in terms of left ventricular filling pres-
sure and cardiac muscle and pump function (cardiac
index). However, subgroup IIA (n = 21) had a stroke
index significantly less than normal, while subgroup lIB
had a significantly increased stroke index and myo-
Ventricular dysfunction with reduced cardiac output is char-
acteristic of alcoholics with cardiomyopathy, a majority of
whom do not have cirrhosis (1-3). This is in contrast to
alcoholic patients with cirrhosis, many of whom have a high
cardiac output (4-6). It has been reported that some patients
with cirrhosis develop a decrease in cardiac function after
exercise (7) or increased resistance to left ventricular ejec-
tion (8). Of particular interest is the effect on cardiac hemo-
dynamics in patients with cirrhosis who receive vasopressin
therapeutically, which reduces cardiac output (9) or a por-
tacaval shunt, which may increase output (10), In addition,
the hypervolemia that occurs after surgical intervention with
a LeVeen shunt can also be associated with altered hemo-
dynamics (10),
The present study was undertaken to 1) compare cardiac
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cardial contractility with a diminished systemic arterial
resistance. Similar hepatic abnormalities were present
in both subgroups. In group III, left ventricular end-
diastolic and aortic mean pressures were significantly
elevated compared with values in normal subjects, while
cardiac index and indexes of ventricular contraction and
relaxation were abnormal.
Further examination of patients with cirrhosis indi-
cated that the responses to volume or pressure incre-
ments in terms of the level of stroke work for a given
filling pressure were most abnormal in group IIA, ap-
proximating those of group III. Thus, although overt
cardiomyopathy is infrequent in patients with cirrhosis,
asymptomatic myocardial disease may assume clinical
importance during volume or pressure overload.
and hepatic hemodynamics in alcoholics hospitalized with
liver or cardiovascular disease; and 2) to elucidate factors
that determine the cardiac response to therapeutic modalities
for patients with cirrhosis that may decrease or increase
cardiac function.
Methods
Study patients. Sixty-nine patients with a history of
heavy ethanol consumption and symptoms and signs of liver
or heart disease, and 13 nonalcoholic subjects were studied
by right and left heart catheterization in the basal postab-
sorptive state under local procaine analgesia. The 13 non-
alcoholic control subjects (group I) were studied because of
a heart murmur or cardiac symptoms, or both, and were
found to be hemodynamically normal; none had an abnormal
electrocardiogram or chest X-ray film.
The 37 patients in group II were admitted because of
features of hepatic disease (Tables 1 and 2). They were
classified into two subsets on the basis of a low (group IIA,
21 patients) or high (group lIB, 16 patients) cardiac output.
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Table 1. Clinical Features
Absent
Age BSA Systolic Abn. Septal
Group M/F (yr) (m2) S3 S. Murmur NSR Axis Q Wave LAA LVH iCTR
I: Normal 10/3 42.5 1.76 0 8 12 0 0 2 0
subjects ±2.9 ±0.04
(n = 13)
II: Patients with 3017 47.6 1.75 4 36 2 0 2 0
cirrhosis ±2.0 ±0.04
(n = 37)
III: Patients without 26/6 44.0 1.82 2 4 5 23 5 7 4 5 0
cirrhosis ± 1.8 :±:0.06
(n = 32)
Valves are mean ± standard error. Abn. axis = abnormal electrical axis; BSA = body surface area; CTR = cardiothoracic ratio; LAA = left atrial
abnormality; LVH = left ventricular hypertrophy; M/F = male/female ratio; NSR = normal sinus rhythm; i = increased.
The remaining 37 alcoholic patients (group Ill) were found
to have vascular symptoms without heart failure or X-ray
evidence of cardiomegaly during hospitalization (Table 1).
They had no evidence of cirrhosis.
Informed consent was obtained in each case. All subjects
were studied at rest; in selected patients, studies were re-
peated after the receipt of dextran, angiotensin or antidi-
uretic hormone injection (Pitressin). Complete blood counts
and blood chemistry values were obtained before
catheterization.
Assessment of liver function. A liver biopsy was per-
formed in 10 of the alcoholics without cirrhosis and in each
of those with cirrhosis. The biopsy specimen was examined
independently by two examiners, a hepatologist and a pa-
thologist, before the hemodynamic study. The results of this
study were characterized as described earlier (11). A 7F
125 cm long Cournand catheter was placed in the hepatic
vein to measure hepatic hemodynamics. After measurement
of free hepatic vein and hepatic wedge pressures, hepatic
blood flow was measured by the indocyanine green dye
method (12). The indocyanine green dye extraction was
calculated according to the method of Leevy et al. (12).
Cardiac catheterization. Catheters were positioned in
the main pulmonary artery and left ventricular apex. The
left ventricle was entered by retrograde catheterization via
the right brachial artery (7F 80 cm long NIH catheter). The
right heart study was performed using a 7F 120 cm long
Swan-Ganz catheter (Edwards Laboratories, Santa Ana,
California). The Statham transducers for measurement of
left ventricular and aortic (P23Gb) and right-sided (P23Db)
pressures were placed at the midchest level and balanced
for equal sensitivity. Arterial catheters of this dimension
have been compared in our laboratory with the Millar cath-
eter micromanometer (Millar Instruments, Houston, Texas)
and have given equivalent aortic and ventricular systolic and
end-diastolic pressures in accordance with prior studies (13).
The first derivative of the left ventricular pressure increase
(dP/dt) was obtained using the resistance-capacitance dif-
ferentiating circuit (time constant 1.1 ms) connected to the
output of the pressure channel.
Table 2. Laboratory Data in Group II (alcoholic patients with cirrhosis) (mean ::I:: standard error)
A. Serum Values
Hct Albumin Bilirubin SGOT SGPT Alk. Pase ICG C
Subgroup (%) (g/100 ml) (mg/IOO ml) (units) (units) (units) (mg/min)
IIA 36.8 :±: 0.4 2.9 :±: 0.1 1.5 ± 0.2 41 ± 4 43 ± 7 85 ± II 0.21 :±: 0.03
lIB 34.6 :±: 0.5 3.2 ± 0.4 1.9 ± 0.4 49 ± 3 39 :±: 4 65 :±: 11 0.22 ± 0.03
B. Liver Morphology*
Size
(cm) F Ad R B N 0
IIA 15.6 ± 9 2.2 ± 0.2 0.83 :±: 0.2 2.6 ± 0.2 0.22 :±: 0.1 1.8 ± 0.1 0.5 ± 0.1 0.1 ± 0.06
lIB 14.6 ± 2 2.8 ± 0.1 0.36 ± 0.2 3.0 ± 0.1 0.1 :±: 0.1 1.5 ± 0.1 0.2 ± 0.1 0.3 ± 0.1
Ad = adipose tissue; Alk. Pase = alkaline phosphatase; B = bile stasis: F = fibrosis: Hct = hematocrit: I = inflammation: ICG C = indocyanine
green clearance; N = necrosis; 0 = obliteration; R = regeneration; IIA and liB = subgroups with decreased and elevated cardiac output, respectively.
• All in plus (on a scale of 1+ to 4 +) on microscopy.
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Cardiac output was measured by injecting 10 ml of nor-
mal saline solution at room temperature through the prox-
imal lumen in the right atrium (14,15). The temperature
change was detected by the thermistor in the pulmonary
artery and cardiac output was displayed by an Edwards
computer in liters/min. Three or four successive curves were
averaged to calculate the forward flow. Stroke volume and
stroke work were obtained as reported previously. Pres-
sures, left ventricular dP/dt and electrocardiogram were re-
corded on an Electronics for Medicine DR-12 recorder.
Left ventricular function and contractility were assessed
in several ways. The left ventricular pump function was
reflected by performance characteristics such as stroke vol-
ume and stroke work and by stroke work normalized for
simultaneous end-diastolic pressure (16). Assuming a uni-
form elastic constant, velocity of the contractile element at
peak dP/dt was calculated as the ratio of dP/dtmax to simul-
taneous left ventricular pressure in accordance with Levine
and Britman (17). If the value for the elastic stiffness con-
stant is taken as unity, the units are muscle lengths per
second (MUs). A recently described index of contractility
was also obtained from the isovolumic relaxation phase of
the cardiac cycle (18). The ratio of dP/dt min to end-systolic
pressure at the dicrotic notch was obtained by dividing the
peak negative dP/dt by the end-systolic dicrotic notch pressure.
The state of left ventricular myocardium was further ex-
plored in terms of relaxation properties. Two methods de-
scribing this phase of the cardiac cycle were used. Peak
negative dP/dt, which always occurs during isovolumic re-
laxation, has proved to be a reproducible measure of the
rate of relaxation (19). However, because it is shown to be
affected by contractility, end-systolic volume and afterload
(19), the isovolumic relaxation was characterized in this
study by normalizing the negative dP/dt for simultaneous
pressure-the rate of relaxation of contractile element-the
units of relaxation being muscle lengths per second (20).
Increments in volume and pressure. To assess the in-
fluence of acute increases in circulating blood volume, 27
subjects including 3 normal persons received 500 ml of
dextran intravenously at a rate of 48 mllmin (21). Resistance
to left ventricular ejection was achieved by infusing angio-
tensin intravenously (22) in six patients without cirrhosis
and five normal subjects at a rate of 1.5 to 3 j.Lg/min to
augment the aortic-diastolic pressure by 15 mm Hg and
continuing at that rate for 15 minutes. The average dose
administered was 2.7 j.Lg/min. Twenty-four patients with
cirrhosis received vasopressin (instead of angiotensin) in-
fusion at a rate of 0.005 U/kg per min (23). Similar doses
are used in clinical practice for control of variceal bleeding
(10). The infusion was maintained at that rate for 20 minutes.
After alterations, left ventricular function was measured
once a steady state was obtained. Separate control data were
obtained before the beginning of each new state in patients
who were studied with more than one intervention.
Data analysis. Statistical analyses were performed us-
ing conventional methods for small samples. The difference
between the groups (unpaired) and the different states within
the same group (paired) was evaluated by Student's t test.
Results
Clinical features. The 13 control subjects (group I) in-
cluded in this study had used ethanol only occasionally.
They had no cardiomegaly or history of congestive heart
failure. All 69 alcoholic patients had a history of heavy
consumption for at least 10 years, persistent to the time of
admission. The average age was 45 years with no significant
difference between the normal subjects and the two alcoholic
groups (Table 1). Of the black patients, 38 were men and
11 were women; of the Hispanics, 7 were men and 1 was
a woman. The remainder consisted of 12 Caucasians, 11 of
whom were male.
The 37 alcoholic patients of group II had symptoms,
signs and biochemical evidence consistent with liver cir-
rhosis (Table 2). Four had mild to moderate ascites, four
were icteric but had no electrolyte abnormalities. Hepatic
pressures were elevated, and hepatic blood flow and indo-
cyanine green dye extraction were markedly decreased. There
was no significant difference in any of the functional or
morphologic variables in the two subgroups with cirrhosis.
Five had cardiovascular symptoms that were limited to pal-
pitation or anginal chest pain, or both. Heart size was normal
on chest X-ray film in each case. Four patients had a systolic
ejection murmur at the apex but none had a regurgitant
systolic murmur. All 37 patients of group II had normal
sinus rhythm and normal septal Q waves. Left-axis deviation
was present in two; P waves suggestive of left atrial hy-
pertrophy were also observed in two patients.
None of the patients ofgroup III had clinical or chemical
evidence of liver cirrhosis and histologic studies were neg-
ative in the 10 patients who had liver biopsy. A diastolic
gallop was heard in two patients and one had a systolic
ejection murmur at the apex. All had normal sinus rhythm;
left axis deviation was present in five and one had right
bundle branch block. Of note was the absence of a septal
Q wave in leads I, V5 and V6 in seven patients.
Left ventricular function. Left ventricular function was
normal in the basal state and during preload or afterload
increments (Fig. 1). Neither ventricular performance nor
contractility variables in group II differed from those in the
group I control subjects in the basal state (Table 3). In group
III, these variables differed significantly from those of the
group II alcoholics with cirrhosis and the normal control
subjects.
Cardiac output. Because the cardiac output and sys-
temic resistance varied widely in group II, the patients with
cirrhosis were classified into two subgroups on the basis of
cardiac output and stroke index. Twenty-one patients of
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Figure 1. Effects of increments in volume (left
panel) and systemic arterial pressure (right
panel). The latter was increased by an infusion
of angiotensin II in the normal subjects (group
I) and patients without cirrhosis (group III) and
with vasopressin in patients with cirrhosis (group
II). In contrast to normal subjects. the two al-
coholic groups showed no significant improve-
ment in cardiac work despite a substantial in-
crease in left ventricular filling pressure. LVEDP
= left ventricular end-diastolic pressure; LVSW
= left ventricular stroke work.
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subgroup IIA had a stroke index equal to or within 1standard
deviation of the mean for all patients of group II, while the
cardiac output was significantly reduced from normal (p <
0.03). The stroke index in 16 other patients with cirrhosis
exceeded the mean value of group II by more than 1 standard
deviation and these patients comprised subgroup lIB. In the
latter, velocity of contractile element was also significantly
increased and systemic resistance diminished, in association
with an elevated cardiac output (Fig. 2). The two subgroups
did not differ in terms of liver function and configuration
or hepatic wedge pressure (Fig. 3, Table 2). The hematocrit
was also similar. Arterial oxygen content was 15.6 ± 0.6
vol% in group IIA and 15,1 ± 2.1 vol% in lIB.
Cardiac responses to increases in volume and pressure
(Table 4). After assessment of the basal state the influence
of enhanced volume or pressure was determined in all three
groups. Basal hemodynamic variables under these two con-
ditions differed in the same group because all patients were
not tested with both interventions. Infusion of dextran
produced a mean decrease of hematocrit and serum albumin
by 10 ± 2% (probability [p] < 0.01) with no difference
among the various groups or subgroups. The normal subjects
exhibited a modest increase of filling pressure and stroke
work during infusion of dextran or systemic arterial vaso-
constriction. Patients of group III (without cirrhosis) had a
higher absolute filling pressure level during both interven-
Table 3. Hemodynamics at Rest
Group HR AoM EDP SV CI SW SIP TSR dP/dtm" Vee DTES VIR
Group I: Normal 85 94 9.8 38.3 3.17 51.6 5.3 1.403 2,000 26.4 20.5 43.5
subjects ::t 5 ::t 2 ::t 0.5 ::t 2.8 ::t 0.21 ::t 4.9 0.5 ::t92 ± 82 ± 0.9 ± 1.1 ::t 4.8
(n = 13)
Group II: Patients 77 90 9.8 44.4 3.33 57.7 6.6 1.334 2.147 30.7 24.4 50.9
with cirrhosis ± 2 ::t 2 ± 0.6 ± 2.4 ± 0.17 ± 3.1 ± 0.7 ± 74 ± 130 ± 2.2 ± 1.7 ± 3.4
(n = 37)
P vs. group I NS NS NS NS NS NS NS NS NS NS NS NS
Group III: Patients 76 104 12.9 34.9 2.61 48.2 4.4 1.736 1,581 18.3 17.8 31.7
without cirrhosis ± 2 ± 3 ± 1.0 ::t 1.5 ± 0.10 ± 2.5 ± 0.3 ::t 82 ± 84 ± 0.9 ± 0.7 ± 2.2
(n = 32)
p vs. group I NS < 0.01 < 0.008 NS < 0.02 NS NS < 0.01 < 0.001 < 0.0001 < 0.05 < 0.04
P vs. group II NS < 0.0001 < 0.009 < 0.002 < 0.001 < 0.02 < 0.0001 < 0.001 < 0.001 < 0.0001 < 0.001 < 0.0001
AoM = mean aortic pressure (mm Hg); CI = cardiac output (liters/min per m2); dP/dtm", = peak value of first derivative of left ventricular pressure
rise (mm Hg/s); DTES = ratio of peak negative dP/dt to end-systolic pressure at dicrotic notch (mils); EDP = left ventricular end-diastolic pressure
(mm Hg); HR = heart rate (beats/min); SIP = ratio of stroke work to end-diastolic pressure; SV = stroke volume (mllm2); SW = stroke work (g-
m/m2); TSR = total systemic resistance (dynes's'cm -5); V" = velocity of contractile element (mils). VIR = rate of relaxation of contractile element
(ml/s).
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Figure 2. Hemodynamic variations in pa-
tients with cirrhosis. Despite a significantly
higher cardiac output and lower systemic
resistance in the 16 patients of group lIB,
the other functional indexes were not sig-
nificantly different from those of patients
in group IIA. Significance of differences
between these two subgroups is indicated
by the p value at the bottom of the bars.
The dots and asterisks at the top of these
bars indicate the significance of differences
from those in patients without cirrhosis and
normal subjects, respectively. Vce = ve-
locity of contractile element.
HEART RATE MEAN AORTIC PRESSURE END-DIASTOLIC PRESSURE
•
80 92 12
" Li'E..... 70 84 8'"~LIJ<Xl 60 76 4
ot ot 01 ~
o GROUP An' 21; rmI GROUP B n' 16; • P VS. MYOPATHY <0.05; *P VS. NORMAL <0.05
4.8
CARDIAC OUTPUT SYSTEMIC RESISTANCE 36 Vee• * 1800 *
3.2 "? 1200 *• 32
N 5~ ..... uu .,
" :l: ~~ ..... E'"1.6 LIJ 600 28z
>-<:>
0 0 24
P Avs. B< 0001 0001
tions and a smaller stroke work increment. Patients of group
IIA (with cirrhosis) had no increase in left ventricular stroke
work despite a significant increase of left ventricular end-
diastolic pressure. In contrast, patients in group liB re-
sponded to dextran infusion with a significant increase of
stroke work and a relatively modest increase of filling pres-
sure (p versus group I < 0.01). In contrast to findings in
normal subjects, increased systemic resistance after vaso-
pressin caused no increased stroke output or stroke work
despite a similar increment of end-diastolic pressure (each
p versus I < 0.05). The patients with cirrhosis in both
subgroups starting at different basal levels of stroke work
responded similarly to vasopressin. It is noteworthy that
simultaneously measured hepatic wedge pressure declined
by 25 ± 4% (p < 0.01) in response to the neurohormone.
Discussion
Cardiac function in chronic alcoholism without cir-
rhosis (group III). This study supports the view that there
are different stages of cardiac involvement associated with
chronic alcoholism. Thus, in patients without cardiac symp-
toms or evidence of cardiomegaly, abnormal left ventricular
function has been described in patients without hepatic cir-
rhosis in the basal state and after increased afterload during
infusion of angiotensin (I). In our patients without cirrhosis
who had cardiac symptoms without cardiomegaly (group
III), left ventricular malfunction was observed in the basal
state and during increased preload or afterload when com-
pared with function in the normal subjects. Although mean
aortic pressure was slightly higher than in the control sub-
jects, this did not correlate with the abnormal systolic or
diastolic ventricular variables. Thus, after symptoms have
dissipated, cardiac function appears to be comparable with
that of alcoholic subjects without cardiac symptoms (l).
Septal Q wave. The absence of a septal Q wave with a
normal vertical frontal QRS axis, in 7 of the 32 patients
with symptoms, in contrast to group II, supports the view
that a degree of cardiac disease exists in the former. How-
ever, as noted previously in patients without cirrhosis (24),
this indirect evidence of septal abnormality can exist in
alcoholics without cardiac symptoms.
Cardiac function in patients with cirrhosis (group
II). Subjects with clinical and histologic evidence of al-
coholic cirrhosis without symptoms or signs of cardiac in-
volvement had two distinct patterns of left ventricular func-
tional status. Slightly more than a majority (group IIA) had
a reduction of cardiac output in the basal state. During
volume loading or increased afterload, or both, left ven-
tricular function was substantially depressed. There was no
significant stroke work increment after these interventions
in contrast to the modest increase seen in the group III pa-
tients. In the remaining patients with cirrhosis (group liB),
cardiac output was significantly elevated in the basal state
in association with diminished systemic peripheral arterial
resistance. That the elevated cardiac output was presumably
secondary to the diminished peripheral resistance and not
related to a primary hypercontractile state is supported by
the observed failure of stroke work to increase when after-
load was enhanced. The high output state in these patients
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natively, patients with cirrhosis and some degree of portal-
systemic shunting of blood flow may have high blood glu-
cagon levels in the circulation (25) which may also alter
hemodynamics in a manner fitting the description of group
lIB. In addition, reduced vasoconstrictive response to nor-
epinephrine (26) and angiotensin (27,28) has been reported
in patients with cirrhosis, but simultaneous observations on
cardiac hemodynamics have not been made.
Role of systemic resistance. It has been inferred pre-
viously that the absence of clinical symptoms of cardio-
myopathy in subjects with cirrhosis could be attributed to
the lower systemic vascular resistance (8). However, the
presence of undiminished peripheral vascular resistance in
more than half of patients with cirrhosis suggests that this
is not the predominant mechanism. It is conceivable that
nutritional factors have a bearing on this question. As liver
disease progresses, important nutritional deficiencies may
occur (29) that may be mild in extent but may influence the
appearance of some of the cardiac abnormalities associated
with cardiomyopathy, including the synthesis and degra-
dation of interstitial collagen and the development of cardiac
hypertrophy. In addition, genetic factors that regulate the
development of disease in individual organs may vary from
one ethanol addict to another.
Implications. The presence of clinical dysfunction of
the left ventricle in patients with cirrhosis with low cardiac
output in the basal state suggests that under unusual stresses
clinically important cardiac decompensation may occur. Thus,
during surgical intervention with the LeVeen shunt in pa-
tients with cirrhosis, pulmonary congestion has been noted
as an important complication.
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Figure 3. Hepatic pressures and flow and indocyanine green dye
extraction (ICGE) indicating no differences between subgroups
IIA and lIB (patients with cirrhosis and diminished or elevated
cardiac output, respectively), Significance of variation from the
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with cirrhosis was not associated with hemodynamically
significant anemia or arterial hypoxia.
However, a thiamine deficiency state that is insufficient
to produce the classic beriberi syndrome could result in ar-
teriolar dilation and diminished systemic resistance. Alter-
We express our appreciation to Doris Dolan, RN, Marguerite Brown, LPN,
Richard Sullivan, BS and Jerome Mathias for their assistance in the cath-
eterization laboratory. We thank Paul Zweil, PhD for his help in deter-
mination of indocyanine green extraction and Martin Feuerman for his
efforts in analyzing the data, We are grateful to Anne Binetti and Linda
Crincoli for the preparation of the manuscript.
Table 4. Cardiovascular Response to Increments in Volume and Pressure (mean value ± standard error of the mean)
Increase in Volume Increase in Pressure
Group I (n = 3) Group II (n = 17) Group III (n = 7) Group I (n = 5) Group II (n = 24) Group III (n = 6)
Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post
Heart rate 67 69 79 78 76 78 94 88 77 78 85 79
(beats/min) ±5 ±7 ±3 ±3 ±6 ±6 ±7 ±9 ±3 ±3 ±10 ±5
Mean aortic 107 114 94 95 113 III 98 121* 87 90*tt 101 125*
pressure (mm Hg) ± 12 ± 12 ±3 ±4 ±4 ±7 ±6 ±3 ±3 ±4 ±7 ±5
Systemic 1540 1403 1640 1371* 2036 1728 1379 1488 1348 1619* 1678 2310*
resistance ±93 ± 192 ± 122 ± 118 ±295 ±270 ± 140 ±304 ±73 ±87 ±207 ±250
(dynes's'cm -5)
*p < 0.05 to 0.001, probability of unpaired t evaluating the intergroup difference; tp < 0,05 vs. Group I; tp < 0.05 vs, Group II. Group I =
normal subjects; Group II = patients with cirrhosis; Group III = alcoholics without cirrhosis, The normal subjects and alcoholic patients without cirrhosis
received angiotensin instead of vasopressin,
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